Logo

STKL

SunOpta Inc.

STKL

SunOpta Inc. • NASDAQ
$3.76 ▲ 5.03% (+0.18)
Market Cap $444.50 M
52w High $8.05
52w Low $3.32
Dividend Yield 0%
P/E 94
Volume 525.10K
Outstanding Shares 118.22M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $205.41M ▲ $21.114M ▲ $816K ▼ 0.397% ▼ $0 ▼ $16.925M ▼
Q2-2025 $191.489M ▼ $17.874M ▼ $4.351M ▼ 2.272% ▼ $0.036 ▼ $20.398M ▲
Q1-2025 $201.628M ▲ $19.832M ▲ $4.811M ▲ 2.386% ▲ $0.04 ▲ $19.791M ▲
Q4-2024 $193.669M ▲ $17.834M ▼ $-9.637M ▼ -4.976% ▼ $-0.084 ▼ $11.732M ▲
Q3-2024 $176.216M $22.061M $-5.498M -3.12% $-0.048 $10.606M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $2.225M ▲ $694.102M ▼ $516.069M ▼ $178.033M ▲
Q2-2025 $2.161M ▼ $704.94M ▲ $545.124M ▲ $159.816M ▲
Q1-2025 $2.299M ▲ $690.685M ▲ $535.87M ▲ $154.815M ▲
Q4-2024 $1.552M ▼ $668.527M ▼ $519.933M ▼ $148.594M ▼
Q3-2024 $2.933M $699.326M $523.164M $161.252M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $0 ▼ $0 ▲ $0 ▲ $0 ▼ $0 ▲ $0 ▲
Q2-2025 $4.351M ▼ $-4.178M ▼ $-3.759M ▲ $8.381M ▲ $-138K ▼ $-9.2M ▼
Q1-2025 $4.811M ▲ $22.281M ▼ $-15.154M ▼ $-6.398M ▲ $729K ▲ $7.127M ▼
Q4-2024 $-6.032M ▲ $32.192M ▲ $-8.186M ▼ $-25.628M ▼ $-1.381M ▼ $23.607M ▲
Q3-2024 $-6.214M $17.16M $-2.567M $-15.36M $-257K $11.559M

Revenue by Products

Product Q3-2020Q4-2020Q2-2025Q3-2025
Ingredients
Ingredients
 $0 ▲$0 ▲$0 ▲$0 ▲
FruitBased Foods And Beverages
FruitBased Foods And Beverages
 $90.00M ▲$90.00M ▲$0 ▼$0 ▲
Plant Based Foods And Beverages
Plant Based Foods And Beverages
 $100.00M ▲$120.00M ▲$0 ▼$0 ▲
Global Ingredients
Global Ingredients
 $120.00M ▲$0 ▼$0 ▲$0 ▲

Five-Year Company Overview

Income Statement

Income Statement Revenue has grown nicely over the last few years after an earlier step-down, suggesting the core business is gaining scale, especially in plant-based and “better-for-you” products. Gross profit has kept pace with sales, and operating profit is consistently positive, but margins remain thin, which leaves little room for error on costs or pricing. Earnings at the bottom line are more fragile. The company has posted losses in most of the recent years, with one year showing a particularly large hit, likely tied to one‑off items, restructuring, or portfolio changes. Recent results show improvement, but the business still hasn’t translated its operating progress into reliable, recurring net profits. Overall, the income statement tells the story of a company growing in the right categories, with improving operations, but still working to convert that growth into steady, durable earnings for shareholders.

Balance Sheet

Balance Sheet The balance sheet shows a company that has invested heavily and now carries a sizable debt load relative to its equity. Total assets have come down from earlier peaks as SunOpta has reshaped its portfolio and focused on core areas, but debt has climbed while the equity cushion has shrunk. This mix means financial leverage is meaningful: the company is more sensitive to interest costs and to any downturn in performance than a more conservatively financed peer. Limited disclosure of cash in the summary numbers makes it hard to judge liquidity from this data alone, but the overall picture is of a capital‑intensive business that has leaned on borrowing to fund growth and capacity. In short, the balance sheet supports the growth strategy but leaves less room for unexpected shocks, making ongoing discipline around capital spending and debt reduction important to watch.

Cash Flow

Cash Flow Cash flow looks healthier than the accounting earnings alone might suggest. The business has generated positive operating cash flow in most years, including a solid improvement in the most recent period, which indicates that the core operations do bring in cash even when reported earnings are weak. Free cash flow has been volatile and negative in some years, largely because SunOpta has been in a heavy investment phase, building and upgrading plants and capabilities. Those high capital expenditures are now easing, and free cash flow recently turned positive again, a constructive sign that the investment cycle may be moving from build‑out toward harvesting returns. The key question going forward is whether the company can sustain positive free cash flow consistently while still funding targeted growth projects and managing its debt load.

Competitive Edge

Competitive Edge SunOpta holds a strong niche in plant-based and health‑oriented foods, especially as a leading maker of shelf‑stable plant-based beverages in North America. Its expertise in aseptic processing, broad range of packaging formats, and national manufacturing footprint make it an attractive partner for major brands and retailers. A large part of its business is co‑manufacturing and private label production, where customers rely on SunOpta’s specialized facilities and supply chain. This creates switching costs and tends to lock in long‑term relationships, which can provide steady volume and some protection against new entrants, given the high capital needed to compete at scale. At the same time, SunOpta operates in a highly competitive space with large consumer packaged goods companies and emerging plant-based brands. Its reliance on a relatively concentrated customer base and on the continued growth of plant-based categories are important ongoing risks. The company’s edge is more about operational scale and integration than about owning dominant consumer brands.

Innovation and R&D

Innovation and R&D Innovation at SunOpta is tightly linked to manufacturing technology, sustainability, and new product platforms rather than classic lab‑driven R&D alone. The company has invested heavily in advanced aseptic processing and a modern plant network, highlighted by its large Texas facility designed for efficiency, flexibility, and lower environmental impact. On the product side, SunOpta is expanding within plant-based beverages and moving into adjacent categories like creamers, nutritional drinks, and fruit‑based snacks, including functional offerings with added health benefits. Its work on upcycled ingredients, such as oat‑derived powders, and on more sustainable packaging, shows a focus on both cost and consumer trends. Overall, SunOpta’s innovation is about turning technical and supply‑chain capabilities into new, value‑added products and formats for its brand and private‑label partners. The main execution risk is making sure this new capacity stays well utilized and that innovation translates into better margins, not just more volume.

Summary

SunOpta is a focused player in plant-based and better‑for‑you foods, showing solid revenue growth and clear operational strengths in advanced beverage processing and integrated sourcing. Its plant network, customer relationships, and sustainability initiatives give it a defensible position in a growing niche. Financially, the company is in a transition phase: sales and operating profits are moving in the right direction, but net earnings have been inconsistent, and leverage has increased as it invested heavily in new capacity. Cash generation is improving as big projects roll off, which could support gradual strengthening of the balance sheet if maintained. The opportunity lies in leveraging its manufacturing scale and innovation pipeline to deepen customer partnerships and improve profitability. The main risks are thin margins, higher debt, dependence on a competitive plant-based market, and the need to fully utilize its expanded facilities. How well SunOpta converts its operational advantages into steady profits and free cash flow will be the key factor to watch over the next several years.

NEWS

November 5, 2025 · 5:00 PM UTC

SunOpta Announces Third Quarter Fiscal 2025 Financial Results

Read more

October 29, 2025 · 10:54 AM UTC

SunOpta Inc. to Participate in Upcoming Investor Conference

Read more